Wed, 25 Apr 2018 06:38:28 GMT
Shire likely to recommend Takeda's $64B bid to shareholders
On Tuesday, the drug maker Shire stated it was eager to recommend the last Takeda Pharmaceutical's bid worth $64B to shareholders, raising chances to clinch the biggest takeover of a drug firm this year.